Chylous Ascites and Pleural Effusion Treated With Intravenous Octreotide

Chylous ascites (CA) is uncommon in cirrhosis. It often presents as diuretic-resistant ascites and is associated with increased mortality. Diagnosis is done by the detection of triglyceride-rich ascitic fluid. There are no published guidelines on the management of CA. We describe the case of a middl...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghimire, Subash, Shah, Harshil, Paudel, Sanjay, Yang, Tsu Jung, Khan, Hafiz M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2020
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7370588/
https://www.ncbi.nlm.nih.gov/pubmed/32699669
http://dx.doi.org/10.7759/cureus.8669
_version_ 1783561006303150080
author Ghimire, Subash
Shah, Harshil
Paudel, Sanjay
Yang, Tsu Jung
Khan, Hafiz M
author_facet Ghimire, Subash
Shah, Harshil
Paudel, Sanjay
Yang, Tsu Jung
Khan, Hafiz M
author_sort Ghimire, Subash
collection PubMed
description Chylous ascites (CA) is uncommon in cirrhosis. It often presents as diuretic-resistant ascites and is associated with increased mortality. Diagnosis is done by the detection of triglyceride-rich ascitic fluid. There are no published guidelines on the management of CA. We describe the case of a middle-aged female who presented with CA secondary to cirrhosis, and the challenges associated with her treatment and her management with the use of intravenous octreotide.
format Online
Article
Text
id pubmed-7370588
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-73705882020-07-21 Chylous Ascites and Pleural Effusion Treated With Intravenous Octreotide Ghimire, Subash Shah, Harshil Paudel, Sanjay Yang, Tsu Jung Khan, Hafiz M Cureus Internal Medicine Chylous ascites (CA) is uncommon in cirrhosis. It often presents as diuretic-resistant ascites and is associated with increased mortality. Diagnosis is done by the detection of triglyceride-rich ascitic fluid. There are no published guidelines on the management of CA. We describe the case of a middle-aged female who presented with CA secondary to cirrhosis, and the challenges associated with her treatment and her management with the use of intravenous octreotide. Cureus 2020-06-17 /pmc/articles/PMC7370588/ /pubmed/32699669 http://dx.doi.org/10.7759/cureus.8669 Text en Copyright © 2020, Ghimire et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Internal Medicine
Ghimire, Subash
Shah, Harshil
Paudel, Sanjay
Yang, Tsu Jung
Khan, Hafiz M
Chylous Ascites and Pleural Effusion Treated With Intravenous Octreotide
title Chylous Ascites and Pleural Effusion Treated With Intravenous Octreotide
title_full Chylous Ascites and Pleural Effusion Treated With Intravenous Octreotide
title_fullStr Chylous Ascites and Pleural Effusion Treated With Intravenous Octreotide
title_full_unstemmed Chylous Ascites and Pleural Effusion Treated With Intravenous Octreotide
title_short Chylous Ascites and Pleural Effusion Treated With Intravenous Octreotide
title_sort chylous ascites and pleural effusion treated with intravenous octreotide
topic Internal Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7370588/
https://www.ncbi.nlm.nih.gov/pubmed/32699669
http://dx.doi.org/10.7759/cureus.8669
work_keys_str_mv AT ghimiresubash chylousascitesandpleuraleffusiontreatedwithintravenousoctreotide
AT shahharshil chylousascitesandpleuraleffusiontreatedwithintravenousoctreotide
AT paudelsanjay chylousascitesandpleuraleffusiontreatedwithintravenousoctreotide
AT yangtsujung chylousascitesandpleuraleffusiontreatedwithintravenousoctreotide
AT khanhafizm chylousascitesandpleuraleffusiontreatedwithintravenousoctreotide

Ejemplares similares